Skip to main content

Table 1 Baseline characteristics of the patients

From: Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

 

N (%) or mean ± SD

Reference value

Patients

150

 

Age at diagnosis (years)

32.0 ± 1.0

 

Male sex

108 (72.0)

 

IBD

108 (72.0)

 

Overlap with autoimmune hepatitis

13 (8.7)

 

Dominant stenosis

100 (66.7)

 

Dominant stenosis at first diagnosis

22 (14.7)

 

Number of ERCs

618

 

Number of ERCs per patient

3.0 ± 0.3

 

Laboratory parameters at baseline

  

Bilirubin (mg/dL)

0.9 ± 0.3

-1.1

ALT (IU/L)

92.5 ± 9.6

-23

AST (IU/L)

63.7 ± 6.2

-19

AP (IU/L)

252.1 ± 20.2

-175

GGT (IU/L)

267.0 ± 28.5

-60

Albumin (g/dL)

42.0 ± 0.5

35-55

Mayo risk score

-0.12 ± 0.1

 
  1. IBD, inflammatory bowel disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AP, alkaline phosphate; GGT, γ-glutamyltransferase; ERC, endoscopic retrograde cholangiography.